TEMOZOLOMIDE 250 mg Pill: gray & white, capsule/oblong, 22mm
The pill with imprint TEMOZOLOMIDE 250 mg (Gray & White, Capsule/Oblong, 22mm) has been identified as Temozolomide 250 mg and is used for Glioblastoma Multiforme, and Anaplastic Astrocytoma. It belongs to the drug class alkylating agents and is not a controlled substance.
Images for TEMOZOLOMIDE 250 mg
Temozolomide
- Imprint
- TEMOZOLOMIDE 250 mg
- Strength
- 250 mg
- Color
- Gray & White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- IDT Australia Limited
- National Drug Code (NDC)
- 64144-0506
- Inactive Ingredients
-
lactose anhydrous,
sodium starch glycolate type A potato,
silicon dioxide,
stearic acid,
tartaric acid,
gelatin,
methylparaben,
propylparaben,
sodium lauryl sulfate,
ferrosoferric oxide,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "TEMOZOLOMIDE 250 mg"
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.